Beyond the dogma: novel β2-adrenoceptor signalling in the airways

Giembycz M. A., Newton R.

Source: Eur Respir J 2006; 27: 1286-1306
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giembycz M. A., Newton R.. Beyond the dogma: novel β2-adrenoceptor signalling in the airways. Eur Respir J 2006; 27: 1286-1306

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016

Modulation by cAMP of IL-1β-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells
Source: Eur Respir J 2003; 22: 220-226
Year: 2003



Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli
Source: Eur Respir J 2006 Oct 01;28(4):703-711
Year: 2006



Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013


Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM)
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015

PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005


The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016


Regulation of eotaxin gene transcription by peroxisome proliferator-activated receptor γ agonists in human airway smooth muscle cells: interactions with glucocorticoids and β2-agonists
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005


Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease?
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013


Estrogen requires the NO-cGMP-PKG pathway in order to prevent the hyper-responsiveness of asthmatic tracheal smooth muscle to carbachol
Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina
Year: 2005

Functional Wnt signalling in airway smooth muscle from asthma patients
Source: Annual Congress 2010 - Airway smooth muscle cells
Year: 2010


Epac1 and Epac2 regulate airway smooth muscle tone in mice
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015


Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
Source: Eur Respir J 2008; 32: 555-562
Year: 2008